National Cancer Center Singapore [NCCS], released a statement that they will be launching a new therapeutic cancer vaccine treatment. This is a US FDA-approved, human clinical trial for a cancer therapy that is based on the human immune system. The NCCS Trial is significant as it is one of the first trials that is allowed […]
Continue reading
A substantial breakthrough has taken place in the area of cancer treatment studies for ovarian cancer. New research demonstrates great potential for the immunotherpay DPX-Survivac, used to treat women with ovarian cancer. In early studies, patients exhibited great immune response to the therapy, coupled with a low-dose cyclophosphamide. In turn, the FDA has bestowed an […]
Continue readingNew York Governor Andrew Cuomo (D) embarked on a historic trade mission in April and came back with something that could save thousands of lives: a lung cancer vaccine developed in Cuba. CimaVax, a vaccine for treating lung cancer, is coming to the United States for clinical trials. The vaccine was thoroughly studied for a quarter […]
Continue reading
68-year old Sandy Hillburn was one of the university patients who reaped the benefits of experimental cancer therapy. The cancer researchers at Duke University claim that this experimental cancer therapy has helped patients prolong their lives. During an interview, Hillburn stated that she very fortunate to have six grandsons and life-long friends. “I was actually told I […]
Continue reading
Kathy Boltz PhD Researchers are pursuing a new concept in treatment of epithelial cancer, especially head and neck cancer, by using two promising analogs of an old compound that was once studied as a potent antitumor agent, but long ago abandoned because it was too toxic. Their promising findings were published in PLOS ONE (2015; 10.1371/journal.pone.0125322). The […]
Continue reading